Ampio Pharmaceuticals, Inc. filed its 10-K on Mar 27, 2023 for the period ending Dec 31, 2022. In this report its auditor, Moss Adams LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 USD | -18.52% | -8.52% | -89.27% |
04-15 | Ampio Pharmaceuticals, Inc.(NYSEAM:AMPE) dropped from S&P TMI Index | CI |
03-27 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-89.27% | 307K | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- AMPE Stock
- News Ampio Pharmaceuticals, Inc.
- Ampio Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt